These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36533187)

  • 1. Potential immunological effects of gender-affirming hormone therapy in transgender people - an unexplored area of research.
    White AA; Lin A; Bickendorf X; Cavve BS; Moore JK; Siafarikas A; Strickland DH; Leffler J
    Ther Adv Endocrinol Metab; 2022; 13():20420188221139612. PubMed ID: 36533187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Society for Sexual Medicine Position Statement "Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction".
    T'Sjoen G; Arcelus J; De Vries ALC; Fisher AD; Nieder TO; Özer M; Motmans J
    J Sex Med; 2020 Apr; 17(4):570-584. PubMed ID: 32111534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating sex differences in T regulatory cells from cisgender and transgender healthy individuals and patients with autoimmune inflammatory disease: a cross-sectional study.
    Robinson GA; Peng J; Peckham H; Butler G; Pineda-Torra I; Ciurtin C; Jury EC
    Lancet Rheumatol; 2022 Oct; 4(10):e710-e724. PubMed ID: 36353692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune system adaptation during gender-affirming testosterone treatment.
    Lakshmikanth T; Consiglio C; Sardh F; Forlin R; Wang J; Tan Z; Barcenilla H; Rodriguez L; Sugrue J; Noori P; Ivanchenko M; Piñero Páez L; Gonzalez L; Habimana Mugabo C; Johnsson A; Ryberg H; Hallgren Å; Pou C; Chen Y; Mikeš J; James A; Dahlqvist P; Wahlberg J; Hagelin A; Holmberg M; Degerblad M; Isaksson M; Duffy D; Kämpe O; Landegren N; Brodin P
    Nature; 2024 Sep; 633(8028):155-164. PubMed ID: 39232147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
    Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
    J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgender and gender diverse people with endometriosis: A perspective on affirming gynaecological care.
    Jeffrey S; Ashton L; Ferfolja T; Armour M
    Womens Health (Lond); 2024; 20():17455057241251974. PubMed ID: 38742674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
    van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
    J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender minority stress in transgender people: a major role for social network.
    Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G
    J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-Diverse Inclusion in Immunological Research: Benefits to Science and Health.
    Peckham H; Webb K; Rosser EC; Butler G; Ciurtin C
    Front Med (Lausanne); 2022; 9():909789. PubMed ID: 35911383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
    Connelly PJ; Marie Freel E; Perry C; Ewan J; Touyz RM; Currie G; Delles C
    Hypertension; 2019 Dec; 74(6):1266-1274. PubMed ID: 31656099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of gender-affirming health care, and COVID-19 illness, testing, and vaccination among trans Australians during the pandemic: a cross-sectional survey.
    Zwickl S; Ruggles T; Wong AF; Ginger A; Angus LM; Eshin K; Cook T; Cheung AS
    Med J Aust; 2024 Jan; 220(1):23-28. PubMed ID: 37994182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
    Hashemi L; Marijic Buljubasic A; Budoff MJ; Copeland LA; Jackson NJ; Jasuja GK; Gornbein J; Reue K
    JAMA Netw Open; 2024 Jul; 7(7):e2419696. PubMed ID: 38954413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
    BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-affirming hormone therapy: An updated literature review with an eye on the future.
    D'hoore L; T'Sjoen G
    J Intern Med; 2022 May; 291(5):574-592. PubMed ID: 34982475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
    Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
    J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
    Spanos C; Bretherton I; Zajac JD; Cheung AS
    World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.